| Value | ₹0.24 Cr |
|---|---|
| Execution period | 3 years |
BSE filing, NSE: ZENITHHE. Summary written from the filing by ALFA Finder's alert engine.
Zenith Healthcare Ltd: key numbers
- Share price
- ₹3.70
- Market cap
- ₹19.88 Cr
- Revenue (annual)
- ₹10.52 Cr
- Net profit (annual)
- ₹0.01 Cr
- P/E (TTM)
- 474.4×Sector 45.9×
- Promoter holding
- 28.74%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenith Healthcare Ltd
All →Zenith Healthcare Q2 FY27 Results: Net Profit ₹0 Cr
Zenith Healthcare Ltd reported revenue from operations of ₹2 Cr (-13.0% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Zenith Healthcare Board Meeting Date
Zenith Healthcare has scheduled its Board meeting for 28 October 2026 to consider Q1 and H1 uneaudited financial results. No material decisions have been taken yet.
Zenith Healthcare Other Announcement
Zenith Healthcare Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Zenith Healthcare Management Change
Zenith Healthcare Limited has re-appointed Mr. Mahendra C. Raycha as Managing Director for a three-year term. The appointment was approved by the Board following committee recommendations.
- Execution
- 3 years
Zenith Healthcare Annual General Meeting
Zenith Healthcare Limited held its 32nd Annual General Meeting on August 28, 2026. Shareholders considered the adoption of FY26 financial statements and the re-appointment of directors.
Zenith Healthcare Q1 FY27 Results: Net Profit ₹0.1 Cr
Zenith Healthcare Ltd reported revenue from operations of ₹3.4 Cr (+6.2% YoY) and net profit of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr
Other management change announcements
All →GAMCO Management Change
GAMCO appointed Jayshri Tulsyan as Non-Executive Independent Director for 24 months, effective October 31, 2026. Ayushi Khaitan resigned as Non-Executive Non-Independent Director, citing personal reasons.
Dhampur Bio Organics Management Change
Dhampur Bio Organics' VP Financial Planning and Analysis, Harmeet Singh, resigned, effective October 31, 2026. It is a senior management departure.
Shanthala FMCG Products Management Change
Shanthala FMCG removed CFO Yogish Mallya over alleged misappropriation of funds and appointed Ratnakar Rai as CFO. Both changes are effective 31 October 2026.
Zydus Lifesciences Management Change
Zydus Lifesciences announced the resignation of Dr. Amrut Naik, President of International Markets, effective 7 November 2026. Mr. Christoph Stoller has been appointed to the same senior management role from 2 November 2026.
Vahh Chemicals Management Change
VAHH Chemicals Limited appointed Ms. Shubhangi Rajesh Gadia as Company Secretary and Compliance Officer, effective 01 November 2026. The appointment was approved at a board meeting held on 31 October 2026.
Capital India Finance Management Change
Capital India Finance reports that Senior Management Personnel Ravindran Menon resigned, ceasing to be associated with the company from close of business on 31 October 2026. The resignation letter is enclosed.